Overview

Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea

Status:
Terminated

Trial end date:
2005-08-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to assess the safety of the investigational agent, MucoMilk®, a polyclonal-antibody enriched Whey Protein Concentrate 40% (WPC-40) made of milk of immunized cows. Secondary objectives will investigate the effectiveness of MucoMilk® as an aid in the prevention of relapse of C. difficile-associated diarrhea (CDAD).

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University of Pittsburgh

Collaborator:

MucoVax, BV, the Netherlands